MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors

Autor: Ingelshed, Katrine, Melssen, Marit M., Kannan, Pavitra, Chandramohan, Arun, Partridge, Anthony W., Jiang, Long, Wermeling, Fredrik, Lane, David P., Nestor, Marika, Spiegelberg, Diana
Zdroj: In iScience 21 June 2024 27(6)
Databáze: ScienceDirect